Get your free ETF data sample from our comprehensive offerings. Start your free trial→

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
›ETF Issuers›Vanguard›VHT
VHT

Vanguard Health Care ETF

The VHT Exchange Traded Fund (ETF) is provided by Vanguard. It is built to track an index: MSCI US IMI Health Care 25/50 Index. The VHT ETF provides physical exposure, so by buying it you actually own parts of all the 422 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

$299.47
-$3.8 (-1.25%) today
1:30 PM 07/20/26 Closed
1D price range
$299.47$303.84
52W price range
$239.11$310.37
YTD Perf.
+6.12%
YTD Flows
Annualized volatility
Fund AuM
€15.86B
Share class AuM
€15.86B
TTM Yield
Tracking Error
Tracking Difference
ISIN
US92204A5048
TER
0.09%
Inception date
1/26/2004
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 17, 2026
-5%0%5%10%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 05/31/26
Healthcare
97.65%
Consumer Non-Cyclicals
1.83%
Unavailable
0.37%
Other
0.12%
Latest VHT news

FAQ about VHT

VHT is a Passive ETF. This ETF provides exposure to US Health Care Equities.
VHT tracks the MSCI US IMI Health Care 25/50 GTR Index - USD, through a full replication replication method.
VHT carries a total expense ratio (TER) of 0.09%, indicating the annual cost for holding the fund.
VHT was introduced to the market on January 26, 2004. It trades on United States
Vanguard Health Care ETF, VHT, is provided by Vanguard. Learn more about Vanguard here.
VHT oversees €15.86B in assets as of July 17, 2026.
VHT follows a distributing dividend policy, meaning it pays out income to investors. As of July 17, 2026, its 12-month trailing yield was 1.56%.
As of May 31, 2026, VHT has significant geographic allocations in USA and Ireland.
As of May 31, 2026, VHT focuses largely on Healthcare and Consumer Non-Cyclicals.
As of May 31, 2026, VHT holds 422 positions in its portfolio, with 61.30% of assets concentrated in its top 15 holdings.
As of May 31, 2026, VHT top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of VHT is USD.
Data as of 05/31/26
Eli Lilly & Co.
13.99%
Johnson & Johnson
8.44%
AbbVie, Inc.
6.07%
UnitedHealth Group, Inc.
5.44%
Merck & Co., Inc.
4.63%
Thermo Fisher Scientific, Inc.
2.88%
Amgen, Inc.
2.86%
Gilead Sciences, Inc.
2.63%
Intuitive Surgical, Inc.
2.38%
Abbott Laboratories
2.35%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight